![]() It does not provide real-time alerts or alarms in the absence of a user-initiated action for example, it cannot alert users to low blood glucose levels while they are asleep. Risks associated with use of the system may include hypoglycemia or hyperglycemia in cases where information provided by the device is inaccurate and used to make treatment decisions, as well as mild skin irritations around the insertion site. The FDA evaluated data from a clinical study of individuals aged 18 and older with diabetes, and reviewed the device’s performance by comparing readings obtained by the FreeStyle Libre Glucose Monitoring System to those obtained by an established laboratory method used for analysis of blood glucose. High blood sugar levels can lead to heart disease stroke blindness kidney failure and amputation of toes, feet or legs. When the body doesn’t have enough insulin or cannot use it effectively, sugar builds up in the blood. Health professionals and consumers should be aware about the limitations of available scientific evidence for use of this device in any. People with diabetes either do not make enough insulin (type 1 diabetes) or cannot use insulin properly (type 2 diabetes). The FreeStyle Libre Flash Glucose Monitoring System is a glucose monitoring device indicated for detecting trends and tracking patterns in persons aged 4 and older with insulin dependent diabetes mellitus 15. ![]() Typically patients use results of a traditional fingerstick test to make diabetes treatment decisions however, fingerstick testing is not needed to inform appropriate care choices or to calibrate glucose levels with this system.Īccording to the Centers for Disease Control and Prevention, more than 29 million people in the U.S. People with diabetes must regularly test and monitor their blood sugar to make sure it is at an appropriate level, which is often done multiple times per day by taking a fingerstick sample and testing it with a blood glucose meter. “This system allows people with diabetes to avoid the additional step of fingerstick calibration, which can sometimes be painful, but still provides necessary information for treating their diabetes-with a wave of the mobile reader.” Pierre, acting director of the Office of In Vitro Diagnostics and Radiological Health and deputy director of new product evaluation in the FDA’s Center for Devices and Radiological Health. “The FDA is always interested in new technologies that can help make the care of people living with chronic conditions, such as diabetes, easier and more manageable,” said Donald St. It is intended for use in people 18 years of age and older with diabetes after a 12-hour start-up period, it can be worn for up to 10 days. Users can determine glucose levels by waving a dedicated, mobile reader above the sensor wire to determine if glucose levels are too high (hyperglycemia) or too low (hypoglycemia), and how glucose levels are changing. The system reduces the need for fingerstick testing by using a small sensor wire inserted below the skin’s surface that continuously measures and monitors glucose levels. Food and Drug Administration (FDA) approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip (often referred to as a “fingerstick”). If you are resident of another country, please contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.The U.S. Is a product-specific website intended only for residents of India. The product images are for illustrative purposes only. This website and the information contained herein is intended for use by residents of India. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Healthcare Private Limited, except to identify the product or services of the company. ![]() Please read legal notice for further details Other trademarks are the property of their respective owners. FreeStyle, Libre, and related brand marks are marks of Abbott. Always read the label and use as directed.įor more information call Customer Service on 1800 2100 998 Health care professionals and consumers should be aware about the limitations of available scientific evidence for use of this device in any other groups of patients who require diabetes management. The indication for children (age 4 – 17) is limited to those who are supervised by a caregiver at least 18 years old who is responsible for supervising, managing, and assisting the child in using the FreeStyle Libre system and interpreting its readings. The FreeStyle Libre continuous glucose monitoring system is indicated for measuring interstitial fluid glucose levels in people (age 4 and older) with diabetes mellitus.
0 Comments
Leave a Reply. |